Oppenheimer & Co. Inc. trimmed its holdings in Monsanto Company (NYSE:MON) by 10.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 80,903 shares of the basic materials company’s stock after selling 8,942 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Monsanto were worth $9,694,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in MON. Pinnacle Financial Partners Inc. bought a new position in shares of Monsanto in the second quarter valued at about $114,000. Bruderman Asset Management LLC bought a new position in shares of Monsanto in the second quarter valued at about $116,000. Tower Research Capital LLC TRC raised its holdings in shares of Monsanto by 230.1% in the second quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock valued at $128,000 after buying an additional 750 shares during the last quarter. Armbruster Capital Management Inc. raised its holdings in shares of Monsanto by 12.2% in the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock valued at $136,000 after buying an additional 125 shares during the last quarter. Finally, Enterprise Financial Services Corp raised its holdings in shares of Monsanto by 1.2% in the second quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock valued at $164,000 after buying an additional 16 shares during the last quarter. 74.98% of the stock is owned by institutional investors and hedge funds.
In related news, COO Brett D. Begemann sold 22,640 shares of the business’s stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.03, for a total value of $2,717,479.20. Following the completion of the transaction, the chief operating officer now directly owns 85,439 shares in the company, valued at approximately $10,255,243.17. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Nicole M. Ringenberg sold 7,890 shares of the business’s stock in a transaction that occurred on Monday, October 16th. The shares were sold at an average price of $122.25, for a total value of $964,552.50. Following the completion of the transaction, the vice president now owns 38,600 shares of the company’s stock, valued at $4,718,850. The disclosure for this sale can be found here. Insiders have sold a total of 49,236 shares of company stock valued at $5,931,934 over the last 90 days. Corporate insiders own 0.79% of the company’s stock.
Monsanto Company (NYSE MON) traded down $0.26 during trading on Thursday, hitting $118.22. The stock had a trading volume of 1,847,100 shares, compared to its average volume of 1,941,602. The firm has a market cap of $51,930.00, a price-to-earnings ratio of 21.42, a P/E/G ratio of 1.70 and a beta of 1.05. Monsanto Company has a 52 week low of $100.87 and a 52 week high of $122.79. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.35 and a quick ratio of 0.83.
Monsanto (NYSE:MON) last posted its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. The company had revenue of $2.69 billion during the quarter, compared to analyst estimates of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The company’s revenue for the quarter was up 4.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.07 EPS. equities research analysts expect that Monsanto Company will post 5.74 EPS for the current fiscal year.
A number of analysts recently commented on MON shares. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $131.00 price objective for the company in a research report on Tuesday, August 29th. Piper Jaffray Companies set a $128.00 price objective on Monsanto and gave the stock a “buy” rating in a research report on Friday, August 11th. BMO Capital Markets reiterated a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a research report on Friday, September 1st. Barclays PLC reiterated an “equal weight” rating and issued a $124.00 price objective (up from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Finally, Jefferies Group LLC reiterated a “hold” rating and issued a $128.00 price objective on shares of Monsanto in a research report on Friday, September 15th. Eleven investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Monsanto currently has an average rating of “Hold” and an average target price of $124.61.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.